Skip to main content

Advertisement

Table 4 Incidence of gastrointestinal symptoms

From: Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial

Gastrointestinal symptom Placebo (n = 12) Rebamipide (n = 12) P value
Before After Before After Before After
Any 3 5 5 3 0.67 0.33
Abdominal pain 2 3 3 2 0.50 0.50
Heartburn 2 2 3 1 0.50 0.50
Nausea 1 2 1 1 0.76 0.50
Intestinal cramps 0 1 1 0 0.50 0.50
Fullness 1 0 0 0 0.50 1.00
  1. Incidence of gastrointestinal symptoms in each treatment group before the beginning and at the end of the study. P value was calculated comparing incidence of symptoms between placebo and rebamipide groups before and after treatments by Fisher’s exact test